{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:39:49Z","timestamp":1767929989779,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.josat.2025.209796","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T06:05:36Z","timestamp":1756101936000},"page":"209796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Changing patterns and predictors of opioid use disorder and treatment of adults released from state detention in Pennsylvania"],"prefix":"10.1016","volume":"179","author":[{"given":"Liba","family":"Blumberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Calo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mallinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209796_bb0005","series-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update)","author":"Alderks","year":"2017"},{"key":"10.1016\/j.josat.2025.209796_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109863","article-title":"United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder","volume":"247","author":"Benck","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.josat.2025.209796_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209796_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison--a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.josat.2025.209796_bb0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/emj.20.4.381","article-title":"Effect of innappropriate naltrexone use in a heroin misuser","volume":"20","author":"Boyce","year":"2003","journal-title":"Emergency Medicine Journal"},{"key":"10.1016\/j.josat.2025.209796_bb0030","series-title":"Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009","author":"Bronson","year":"2017"},{"issue":"9","key":"10.1016\/j.josat.2025.209796_bb0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/aje\/kwq481","article-title":"Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes","volume":"173","author":"Cain","year":"2011","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.josat.2025.209796_bb0040","author":"Center for Disease Control and Prevention National Center for Health Statistics"},{"key":"10.1016\/j.josat.2025.209796_bb0045","series-title":"Some Methods for Strengthening the Common \u03c72 Tests","author":"Cochran","year":"1954"},{"key":"10.1016\/j.josat.2025.209796_bb0050","author":"Commonwealth of Pennsylvania"},{"key":"10.1016\/j.josat.2025.209796_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109192","article-title":"Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019\u2013December 2020","volume":"232","author":"Cremer","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209796_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109291","article-title":"Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic","volume":"232","author":"Dadiomov","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2025.209796_bb0065","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/add.14729","article-title":"Circumstances of death of opioid users being treated with naltrexone","volume":"114","author":"Darke","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/dar.12205","article-title":"Excess mortality among opioid-using patients treated with oral naltrexone in Australia","volume":"34","author":"Degenhardt","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2025.209796_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108216","article-title":"COVID-19 and treating incarcerated populations for opioid use disorder","volume":"124","author":"Donelan","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209796_bb0080","series-title":"The opioid threat in Pennsylvania","author":"Drug Enforcement Administration","year":"2018"},{"key":"10.1016\/j.josat.2025.209796_bb0085","series-title":"The opioid threat in Pennsylvania","author":"Drug Enforcement Administration [DEA]","year":"2018"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2025.209796_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2017.04.010","article-title":"Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison","volume":"85","author":"Friedmann","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2025.209796_bb0105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09595230701373834","article-title":"Mortality related to pharmacotherapies for opioid dependence: A comparative analysis of coronial records","volume":"26","author":"Gibson","year":"2007","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2025.209796_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2025.209796_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209796_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102768","article-title":"A scoping review of barriers and facilitators to implementation of medications for treatment of opioid use disorder within the criminal justice system","volume":"81","author":"Grella","year":"2020","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209796_bb0125","series-title":"Prisoners in 2004","author":"Harrison","year":"2005"},{"key":"10.1016\/j.josat.2025.209796_bb0130","article-title":"Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data","volume":"147","author":"Hartung","year":"2023","journal-title":"J Subst Use Addict Treat."},{"key":"10.1016\/j.josat.2025.209796_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108690","article-title":"Treatment preference for opioid use disorder among people who are incarcerated","volume":"137","author":"Kaplowitz","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2025.209796_bb0140","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1080\/10826084.2022.2064506","article-title":"The opioid epidemic and the state of stigma: A Pennsylvania statewide survey","volume":"57","author":"Kaynak","year":"2022","journal-title":"Substance Use & Misuse"},{"issue":"10","key":"10.1016\/j.josat.2025.209796_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of Treatment with Medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2\u20133","key":"10.1016\/j.josat.2025.209796_bb0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2007.05.022","article-title":"A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release","volume":"91","author":"Kinlock","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209796_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109308","article-title":"Medications for opioid use disorder during pregnancy: Access and continuity in a state women\u2019s prison facility, 2016\u20132019","volume":"232","author":"Knittel","year":"2022","journal-title":"Drug and Alcohol Dependence."},{"issue":"9","key":"10.1016\/j.josat.2025.209796_bb0160","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209796_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"International Journal on Drug Policy"},{"issue":"5","key":"10.1016\/j.josat.2025.209796_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11920-010-0135-5","article-title":"Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","volume":"12","author":"Krupitsky","year":"2010","journal-title":"Current Psychiatry Reports"},{"issue":"6","key":"10.1016\/j.josat.2025.209796_bb0175","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2025.209796_bb0180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/add.16071","article-title":"Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17","volume":"118","author":"Lim","year":"2023","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2025.209796_bb0185","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/add.13779","article-title":"Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England","volume":"112","author":"Marsden","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.josat.2025.209796_bb0195","author":"National Institute of Corrections"},{"key":"10.1016\/j.josat.2025.209796_bb0200","series-title":"Drug Facts Criminal Justice","author":"National Institute on Drug Abuse","year":"2020"},{"issue":"1\u20132","key":"10.1016\/j.josat.2025.209796_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1(Suppl 1)","key":"10.1016\/j.josat.2025.209796_bb0210","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.drugalcdep.2008.11.005","article-title":"Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions","volume":"103","author":"Oser","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209796_bb0215","author":"Pennsylvania Department of Corrections"},{"key":"10.1016\/j.josat.2025.209796_bb0220","series-title":"Annual statistical report 2021","author":"Pennsylvania Department of Corrections [PADOC]","year":"2021"},{"key":"10.1016\/j.josat.2025.209796_bb0225","series-title":"Medications for opioid use disorder in Pennsylvania jails and prisons","author":"Pennsylvania Institutional Law Project","year":"2022"},{"issue":"3","key":"10.1016\/j.josat.2025.209796_bb0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1300\/J069v24n03_04","article-title":"Linkage with methadone treatment upon release from incarceration: A promising opportunity","volume":"24","author":"Rich","year":"2005","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s40352-022-00199-1","article-title":"The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: A cross-sectional study","volume":"10","author":"Saunders","year":"2022","journal-title":"Health Justice."},{"key":"10.1016\/j.josat.2025.209796_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.socnet.2020.07.007","article-title":"Network integration within a prison-based therapeutic community","volume":"64","author":"Schaefer","year":"2021","journal-title":"Social Networks"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40352-021-00143-9","article-title":"The impact of the opioid crisis on U.S. state prison systems","volume":"9","author":"Scott","year":"2021","journal-title":"Health Justice."},{"key":"10.1016\/j.josat.2025.209796_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/2277-9175.146373","article-title":"The frequency of agitation due to inappropriate use of naltrexone in addicts","volume":"3","author":"Siadat","year":"2014","journal-title":"Advanced Biomedical Research"},{"key":"10.1016\/j.josat.2025.209796_bb0255","series-title":"Use of medication-assisted treatment for opioid use disorder in criminal justice settings","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"issue":"1","key":"10.1016\/j.josat.2025.209796_bb0260","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44369","article-title":"Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US jails","volume":"5","author":"Sufrin","year":"2022","journal-title":"JAMA Network Open"},{"issue":"11","key":"10.1016\/j.josat.2025.209796_bb0265","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/add.15030","article-title":"Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: Results from a national surveillance study","volume":"115","author":"Sufrin","year":"2020","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.josat.2025.209796_bb0270","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.38807","article-title":"Trends in buprenorphine use in US jails and prisons from 2016 to 2021","volume":"4","author":"Thakrar","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209796_bb0275","series-title":"Prisoners in 2014","author":"United States Department of Justice","year":"2015"},{"key":"10.1016\/j.josat.2025.209796_bb0280","series-title":"Prisoners in 2017","author":"United States Department of Justice","year":"2019"},{"key":"10.1016\/j.josat.2025.209796_bb0285","series-title":"Prisoners in 2021 \u2013 Statistical tables","author":"United States Department of Justice","year":"2021"},{"key":"10.1016\/j.josat.2025.209796_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108686","article-title":"Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data","volume":"136","author":"Zhang","year":"2022","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:28:56Z","timestamp":1767914936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S2949875925001754"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209796","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing patterns and predictors of opioid use disorder and treatment of adults released from state detention in Pennsylvania","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209796"}}